These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22759756)

  • 1. Antimicrobial resistance among Gram-positive pathogens in Saudi Arabia.
    Yezli S; Shibl AM; Livermore DM; Memish ZA
    J Chemother; 2012 Jun; 24(3):125-36. PubMed ID: 22759756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the antimicrobial resistance patterns of gram-positive cocci isolated from community-private and university-affiliated hospitals from Puerto Rico.
    Vázquez GJ; Robledo IE; Arroyo A; Nadal E; Rodríguez R; Bermudez M; Colón M
    P R Health Sci J; 2003 Jun; 22(2):131-6. PubMed ID: 12866136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
    Li JT; Li Y; Wang J;
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
    J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Activities of antimicrobial agents against 8,474 clinical isolates obtained from 37 medical institutions during 2000 in Japan].
    Yamaguchi K; Ohno A; Kashitani F; Iwata M; Kanda M; Tsujio Y; Sugiyama T; Toyoshima S; Kato J; Watanabe N; Kaku M; Kanemitsu K; Kunishima H; Kawaguchi H; Okada J; Shimoyama N; Igari J; Oguri T; Kaimori M; Watanabe K; Kobayashi Y; Uchida H; Katayama Y; Sugimoto K; Tashiro H; Kanno H; Yasujima M; Itoh K; Suwabe A; Obata R; Okada M; Kobayashi S; Tsuzimura M; Itoh A; Sumitomo M; Taminato T; Negayama K; Baba H; Makino H; Murase M; Miyamoto H; Minakuchi K; Ishigo S; Takii M; Horii T; Ono J; Takata T; Yamanaka K; Hamazaki N; Tsutsui T; Okabe H; Tatewaki K; Moro K; Hiramatsu K; Saikawa T; Ichiyama S; Nagasawa Z; Aoki Y; Matsushima T; Niki Y; Hirakata Y; Kohno S; Kuwabara M; Nakagawa K; Kageoka T; Hongo T; Yamane N
    Jpn J Antibiot; 2003 Oct; 56(5):341-64. PubMed ID: 14692376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
    Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An antimicrobial resistance surveillance of gram-positive cocci isolated from 12 teaching hospitals in China in 2009].
    Sun HL; Wang H; Chen MJ; Liu YM; Hu ZD; Liao K; Chu YZ; Lei JE; Zhang B; Yu YS; Hu BJ; Sun ZY; Zhang Z; He QY
    Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):735-40. PubMed ID: 21092441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial resistance trends among 5608 clinical Gram-positive isolates in China: results from the Gram-Positive Cocci Resistance Surveillance program (2005-2010).
    Zhao C; Sun H; Wang H; Liu Y; Hu B; Yu Y; Sun Z; Chu Y; Cao B; Liao K; Lei J; Hu Z; Zhang L; Zhang X; Xu Y; Wang Z; Chen M
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):174-81. PubMed ID: 22521693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study using standardized methodology for antimicrobial susceptibility of gram-positive cocci isolated from the Puerto Rico Medical Center.
    Rodríguez JL; Vázquez GJ; Bermúdez M; De Orbeta J; García Y; Rivera Y; Robledo IE
    P R Health Sci J; 2002 Dec; 21(4):343-7. PubMed ID: 12572243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
    Wang Z; Cao B; Liu YM; Gu L; Wang C
    Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fosfomycin for the treatment of infections caused by Gram-positive cocci with advanced antimicrobial drug resistance: a review of microbiological, animal and clinical studies.
    Falagas ME; Roussos N; Gkegkes ID; Rafailidis PI; Karageorgopoulos DE
    Expert Opin Investig Drugs; 2009 Jul; 18(7):921-44. PubMed ID: 19548851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study of in vitro activity of daptomycin against 2679 Gram-positive cocci].
    Zhang FF; Zhao CJ; Wang ZW; Liu WY; Yan W; Peng QS; Jiang S; Guo Y; Liu JB; Chen HB; Li HN; Wang Q; Wang H
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):474-9. PubMed ID: 24059993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of macrolide resistance in Gram-positive cocci from Colombian hospitals: a countrywide surveillance.
    Reyes J; Hidalgo M; Díaz L; Rincón S; Moreno J; Vanegas N; Castañeda E; Arias CA
    Int J Infect Dis; 2007 Jul; 11(4):329-36. PubMed ID: 17320446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).
    Sader HS; Streit JM; Fritsche TR; Jones RN
    Clin Microbiol Infect; 2006 Sep; 12(9):844-52. PubMed ID: 16882289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centres.
    Sader HS; Farrell DJ; Jones RN
    Int J Antimicrob Agents; 2010 Jul; 36(1):28-32. PubMed ID: 20444576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to tigecycline and linezolid among gram-positive isolates collected in the United States as part of the tigecycline evaluation and surveillance trial (TEST) between 2004 and 2009.
    Dowzicky MJ
    Clin Ther; 2011 Dec; 33(12):1964-73. PubMed ID: 22078154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk factors of early fecal carriage of Enterococcus faecalis and Staphylococcus spp and their antimicrobial resistant patterns among healthy neonates born in a hospital setting in central Saudi Arabia.
    El-Kersh TA; Marie MA; Al-Sheikh YA; Al-Agamy MH; Al Bloushy AA
    Saudi Med J; 2016 Mar; 37(3):280-7. PubMed ID: 26905350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. National surveillance of antimicrobial resistance among Gram-positive bacteria in Saudi Arabia.
    Shibl AM; Memish ZA; Kambal AM; Ohaly YA; Ishaq A; Senok AC; Livermore DM
    J Chemother; 2014 Feb; 26(1):13-8. PubMed ID: 24091308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A consideration on the results of nationwide surveillance of antimicrobial susceptibilities--gram-positive cocci and gram-negative cocci].
    Kuroyama M; Okamoto E; Yago K
    Jpn J Antibiot; 1998 Dec; 51(12):764-78. PubMed ID: 10077775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.